Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	80.52	57.42	68.18	93.73	22.92	15.8
Short-Term Investments	-	-	-	0.57	0.55	0.54
Cash & Short-Term Investments	80.52	57.42	68.18	94.3	23.47	16.35
Cash Growth	40.23%	-15.78%	-27.69%	301.79%	43.57%	-40.65%
Other Receivables	2.37	3.13	2.31	1.82	4.23	11.68
Receivables	2.37	3.13	2.31	1.82	4.23	11.68
Prepaid Expenses	3.83	1.99	3.78	2.8	1.62	2.11
Other Current Assets	-	1.21	0.92	0.41	0.41	0.29
Total Current Assets	86.72	63.76	75.2	99.32	29.73	30.44
Property, Plant & Equipment	1.22	1.65	2.22	2.53	1.57	11.56
Other Intangible Assets	0.8	1.09	-	24.56	31.65	44.46
Total Assets	88.75	66.5	77.41	126.42	62.95	86.45
Accounts Payable	1.75	2.35	3.49	2.29	3.17	6.15
Accrued Expenses	3.53	5.75	5.64	4.02	4.32	5.32
Current Portion of Long-Term Debt	-	-	13.33	-	-	15.14
Current Portion of Leases	0.74	0.65	0.56	0.62	0.64	2.59
Current Income Taxes Payable	-	-	-	1.52	-	-
Other Current Liabilities	2.64	0.74	1.36	4.1	0.44	0.68
Total Current Liabilities	14.21	9.49	24.38	12.54	8.57	29.88
Long-Term Debt	-	4.39	-	14.38	16.14	5.37
Long-Term Leases	0.39	0.91	1.48	1.75	1.16	9.32
Other Long-Term Liabilities	1.61	1.18	0.16	9.74	52.05	1.62
Total Liabilities	16.21	15.96	26.01	38.42	77.92	46.19
Common Stock	3.05	2.78	2.48	1.76	1.02	0.29
Additional Paid-In Capital	536.43	486.11	476.52	247.46	161.79	121.68
Retained Earnings	-455.84	-419.63	-404.58	-296.97	-309.69	-146.07
Treasury Stock	-	-1.23	-1.34	-	-	-
Comprehensive Income & Other	-11.1	-17.49	-21.69	135.76	131.92	64.34
Shareholders' Equity	72.54	50.54	51.4	88	-14.97	40.26
Total Liabilities & Equity	88.75	66.5	77.41	126.42	62.95	86.45
Total Debt	6.68	5.95	15.37	16.76	17.94	32.42
Net Cash (Debt)	73.84	51.47	52.81	77.54	5.53	-16.07
Net Cash Growth	43.47%	-2.54%	-31.89%	1301.34%	-	-
Net Cash Per Share	0.51	0.39	0.44	0.70	0.08	-0.90
Filing Date Shares Outstanding	155.15	140.01	124.74	116.73	108	42.48
Total Common Shares Outstanding	154.73	140	124.74	116.73	67.54	19.34
Working Capital	72.52	54.27	50.82	86.78	21.16	0.56
Book Value Per Share	0.47	0.36	0.41	0.75	-0.22	2.08
Tangible Book Value	71.74	49.45	51.4	63.44	-46.62	-4.2
Tangible Book Value Per Share	0.46	0.35	0.41	0.54	-0.69	-0.22
Machinery	-	0.5	0.61	0.35	0.2	0.19
Leasehold Improvements	-	0.71	0.68	0.56	0.16	0.16

Source: S&P Capital IQ. Standard template. Financial Sources.